chrisvoncsefalvay/vaers-outcomes huggingface dataset:
8d p vaccine stiff neck, sore throat; 9d p vaccine hard to get up; swollen glands cervical and in mandibular area, hips hurt; 10d p rash to face, chest/trunk, fever, took Tylenol.
Mother reported child had vaccine Monday and Tues. AM noted (R) leg to have quarter sized area of redness and warm to touch. Mom reports today area is getting smaller without any treatment. She wanted to report she is concerned this is allergic reaction and she does not want child to receive any further doses of PCV.
sick for 3 days; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team.  A patient (no qualifiers provided) received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose number unknown, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: MALAISE (non-serious), outcome "unknown", described as "sick for 3 days". No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Woke up Wed. after 1st anthrax shot around 09:00 am in the morning. Very painful. Called out of work Wed. Went to doctors due to pinched nerve in back, right next to spine. Pain in neck all the way up. Gave such bad migraine I was nauseous. Still persistent and painful.
This case was reported by a consumer via call center representative and described the occurrence of feeling unwell in a 71-year-old male patient who received SHINGRIX for prophylaxis. In May 2018, the patient received the 1st dose of SHINGRIX (intramuscular). In May 2018, 12 hrs after receiving SHINGRIX, the patient experienced feeling unwell and feeling bad. On an unknown date, the outcome of the feeling unwell and feeling bad were recovered/resolved. It was unknown if the reporter considered the feeling unwell and feeling bad to be related to SHINGRIX. Additional details were provided as follows: The patient received SHINGRIX vaccine on right arm. The patient felt sick, described as feeling lousy about 12 hours after the injection. The event resolved after one day. The patient had denied permission to contact their physician.
This spontaneous report was received from a pharmacist refers to unspecified number of patients of unknown demographics. On an unknown date these patients were vaccinated with GARDASIL (dose, frequency, therapy route, lot # and expiry date unspecified) which were improperly stored. No adverse effects were reported. No product quality complaint (PQC) was involved. Outcome of the event was unknown. Reporting pharmacist considered the event to be not related to GARDASIL. This is one of several reports received from the same source (MARRS # 1502USA002011 and MARRS # 1502USA002298). Additional information has been requested.
Triple vessel bypass graft; Fractured wrist/ Wrist fracture; Osteopenia; Leg pain/ Pain in extremity; Diarrhea/ Diarrhoea; Dizzy spells/ Dizziness; Pain in hip/ Arthralgia; Nausea; This spontaneous case was reported by a health care professional and describes the occurrence of CORONARY ARTERY BYPASS (Triple vessel bypass graft), WRIST FRACTURE (Fractured wrist/ Wrist fracture), OSTEOPENIA (Osteopenia), PAIN IN EXTREMITY (Leg pain/ Pain in extremity), DIARRHOEA (Diarrhea/ Diarrhoea), DIZZINESS (Dizzy spells/ Dizziness), ARTHRALGIA (Pain in hip/ Arthralgia) and NAUSEA (Nausea) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.    Co-suspect product included non-company product ADALIMUMAB (HUMIRA) for Rheumatoid arthritis.    The patient's past medical history included Triple vessel bypass graft (Coronary artery bypass). Concurrent medical conditions included Rheumatoid arthritis.   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. and ADALIMUMAB (HUMIRA) (Subcutaneous) 40MG/0.4ML, Citrate free. In January 2021, the patient experienced WRIST FRACTURE (Fractured wrist/ Wrist fracture) (seriousness criterion hospitalization), OSTEOPENIA (Osteopenia) (seriousness criterion hospitalization), PAIN IN EXTREMITY (Leg pain/ Pain in extremity) (seriousness criterion hospitalization), DIARRHOEA (Diarrhea/ Diarrhoea) (seriousness criterion hospitalization), DIZZINESS (Dizzy spells/ Dizziness) (seriousness criterion hospitalization), ARTHRALGIA (Pain in hip/ Arthralgia) (seriousness criterion hospitalization) and NAUSEA (Nausea) (seriousness criterion hospitalization). On an unknown date, the patient experienced CORONARY ARTERY BYPASS (Triple vessel bypass graft) (seriousness criterion hospitalization). The patient was treated with IBUPROFEN at an unspecified dose and frequency. At the time of the report, CORONARY ARTERY BYPASS (Triple vessel bypass graft) was resolving, WRIST FRACTURE (Fractured wrist/ Wrist fracture), OSTEOPENIA (Osteopenia) and ARTHRALGIA (Pain in hip/ Arthralgia) had not resolved, PAIN IN EXTREMITY (Leg pain/ Pain in extremity) outcome was unknown and DIARRHOEA (Diarrhea/ Diarrhoea), DIZZINESS (Dizzy spells/ Dizziness) and NAUSEA (Nausea) had resolved.      For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant medications were not provided.  Company comment: Very limited information regarding the events has been provided at this time. Further information has been request.; Sender's Comments: Very limited information regarding the events has been provided at this time. Further information has been request.
1st dose 07-AUG-2019, 2nd dose 26-MAR-2023; This non-serious case was reported by a pharmacist via call center representative and described the occurrence of drug dose administration interval too long in a 25-year-old female patient who received HBV (Engerix B) (batch number AC397, expiry date 31-AUG-2023) for prophylaxis.   Previously administered products included Engerix B (received 1st dose on 7th August 2019).   On 26-MAR-2023, the patient received the 2nd dose of Engerix B. On 26-MAR-2023, an unknown time after receiving Engerix B, the patient experienced drug dose administration interval too long (Verbatim: 1st dose 07-AUG-2019, 2nd dose 26-MAR-2023). The outcome of the drug dose administration interval too long was unknown.   This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.   Additional Information: GSK Receipt Date: 01-MAY-2023 The reporter asked when should patient receive the 3rd dose of the Engerix-b. No reactions reported. The reporter consented to follow up via email. The patient received the 2nd dose of Engerix B late than recommendation, which led to drug dose administration interval too long.
Got shot 8 pm Wed 10/20/10 - immediately felt funny. Sick 10/21, 22, 23, 24 vomiting, weakness, dizziness, no appetite, listless.
ED 8/9/2021 presents with SOB and cough - tests positive for COVID. Requires 4L O2 on admission was on Decadron when he came in. 8/10/21: 5L O2, Decadron and Remdesivir. 8/15/21 pt discharged to home on O2, albuterol, dexamethasone, benzonatate, aspirin, guaifenesin and hydralazine and needs to schedule f/u with primary care in 2 weeks.
4 hours after immunizations, developed marked redness and swelling on left leg and fussy while in clinic. Mom stated redness and swelling has improved quite a bit over past few hours. Plan: start low dose of Benadryl x 1-2 days (dose given in clinic). Occasional Tylenol for discomfort. Border of skin outlined with pen. Follow erythema for worsening / expansion. F'U if worsens.
At 9:00 pm on the evening of the shot, I experienced sever joint & muscle pain.  I could not get comfortable in bed, tossed & turned for several hours.  Finally, at 2:00 am, I just got up, trying to sit or recline to get comfortable.  Most of the entire day I was very uncomfortable, I tried taking Tylenol with no success.  I did sleep better the next evening., but was feeling pain and discomfort all the day.  It was 2 days following the shot before I felt reasonable.
This spontaneous report as received from a health worker on 03-NOV-2014 refers to a patient of unknown age and gender. On an unknown date the patient was vaccinated with a dose of improperly stored GARDASIL (strength, dose and lot # were unknown). The vaccine was at 31 F for 8 hours. No adverse effects were reported. This is one of several reports received from the same reporter. Additional information has been requested.
she was diagnosed by an unspecified physician at a local Urgent Care with the shingles; This spontaneous report was received from a 84-year-old female patient reporting on herself. The patient's pertinent medical history included allergy to penicillin and erythromycin. The patient did not have any concomitant medications. On an unspecified date in 2007, the patient was vaccinated with zoster vaccine live (ZOSTAVAX) for vaccination (dose, route of administration, injection site, lot # and expiration date were not reported). The patient reported, than on 25-APR-2019, the right side of her back was real bright red, and it went down her underarm across chest and down chest. She reported "terrible" stinging blisters. On 29-APR-2019, the patient was diagnosed by an unspecified physician at a local Urgent Care with the shingles. The patient received an unspecified treatment. At the time of the report, the symptoms are resolving.  The relatedness between the event and the suspect product was not provided.
Mild nausea for 1-2 minutes after vaccination in the AM. By afternoon had fatigue and increasing pain in arm surrounding injection site, by evening area became hot to the touch. On exam area is swelling and tenderness distal to injection site over bicep. Fever and lethargy had resolved by next day. By 1/20/2014 swelling/warmth/redness resolved, mild tenderness over bicep persists. 400-600 mg ibuprofen up to 3x daily for pain/fever.
Injection site swollen and redness continuing to occur (2 weeks after injection). No pain or other symptoms. Site itches occasionally, but redness is slowly spreading around arm.
Woke up st 2 am  w sweating and severe pain in left frontal head. Spasm about 30 seconds apart for 5 minutes.  Had to pass a stool  as well.  Next day hurt to even chew on that side or lie on left side and residual pain in affected are (not a headache) day three pain in head subsided
On Monday 8/19/02 R thoracic area back discomfort worse if bends down or twists from side to side. Client reports less discomfort today 8/20/02. 8/22/02 TC to client x 3 follow up-not home. 8/26/02 TC pt's residence states pt moved back and was carrying boxes to the 7th floor without difficulty and without complaints of pain.
Arm still hurts; This spontaneous case was reported by a consumer and describes the occurrence of MYALGIA (Arm still hurts) in a 75-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. unknown) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced MYALGIA (Arm still hurts). At the time of the report, MYALGIA (Arm still hurts) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medication was reported. No treatment medication was reported.
This spontaneous report as received from a registered nurse refers to an unspecified number of patients of unknown ages and genders. The patients' medical history was not reported. On an unknown dates the patients were vaccinated with improperly stored doses of RECOMBIVAX HB (route and dosage unknown; lot # M008551 EXP 21-JUN-2018). No adverse event was reported. This is one of several reports from the same reporter. Additional information has been requested.
After shot given he began to have severe shoulder pain (both). As days passed it became worse radiating down below elbows. After a couple of weeks it was still in shoulders, elbows and then continued into wrist and fingers. It continues to this day with swelling. 08/04/04: 5 months later!!Follow up: Bilateral pian. Shoulders to finger tips jints. Not consistant, follows no pattern. Use of arms severely diminished. Scale 1-10 runs 6-10. Arm activity can cause pain. Life style completely changed as of 3/4/04. 9.5 months later!!!
Two days after my 2nd vaccine I was unable to hear out of my left ear (same side I received the shot) Doctor prescribed antibiotics feeling it may be a severe bacterial infection. I've taken for 7 days and no improvement in hearing out of my left ear.  It's been over two weeks and I am unable now to hear out of my left ear. I've never had ear infections or issues hearing, however, since the 2nd vaccine I can not hear out of my left ear!
I had a sore arm and I felt tired for a day. On 09/14/2022 I started feeling like I was getting a cold and I had a fever of 100.7. I took a home test on 09/15/2022 and it was positive for COVID-19. I contacted my doctor and was prescribed PAXLOVID and I started it on 09/15/2022. I had a rebound and felt stuffy on 09/25/2022 and I tested positive for COVID-19 on 09/26/2022. I'm currently taking SUDAFED for congestion and a sinus rinse. For my cough I am taking MUCINEX.
Hurt feet; Hurt neck; Hurt in shoulder, knee , ankle; This spontaneous case was reported by a physician and describes the occurrence of PAIN IN EXTREMITY (Hurt feet), NECK PAIN (Hurt neck) and ARTHRALGIA (Hurt in shoulder, knee , ankle) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 030A21A and 032B21A) for COVID-19 vaccination.    Co-suspect product included non-company product ADALIMUMAB (HUMIRA) injection for Rheumatoid arthritis.    Concurrent medical conditions included Rheumatoid arthritis and Stomach discomfort. Concomitant products included SULFASALAZINE and HYDROXYCHLOROQUINE for Rheumatoid arthritis.   In 2015, the patient started ADALIMUMAB (HUMIRA) (Subcutaneous) 40 mg once a day. On 03-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. In March 2021, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 23-May-2021, the patient experienced PAIN IN EXTREMITY (Hurt feet), NECK PAIN (Hurt neck) and ARTHRALGIA (Hurt in shoulder, knee , ankle). At the time of the report, PAIN IN EXTREMITY (Hurt feet), NECK PAIN (Hurt neck) and ARTHRALGIA (Hurt in shoulder, knee , ankle) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) and mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   The patient is a Non smoker and abstains from Alcohol
Initial information received on 24 October 2013 from a health care professional: A 31-year-old female patient whose medical history and concomitant medication were not reported, received in intramuscular ADACEL (lot number C4385AA, Expiry date unknown) on 18 October 2013. It was reported that the patient was exposed during 12 weeks of pregnancy. Administration site reaction was not reported.  List of documents held by sender: none.
This spontaneous report as received from a pharmacist refers to a patient of unknown age. On an unknown date in January 2013, the patient was vaccinated with the first dose of PNEUMOVAX 23 (dose, route, frequency and lot number not provided). On 22-OCT-2014, the patient was vaccinated with the second dose of PNEUMOVAX 23 (dose, route, frequency and lot number not provided). No adverse effect reported. Additional information has been requested.
I felt really tired the first day which was 12/14/2022. 12/15/2022 I did a home COVID-19 test and it was positive. On the 12/15/2022 Chills, fever of 103.5. I went online to my providers website and requested prescription for PAXLOVID. I felt better that same day.
Patient reported a swollen arm and golf ball sized lump after receiving his first dose of Moderna.
Pregnant and received the vaccine; This spontaneous prospective pregnancy case was reported by an other health care professional and describes the occurrence of MATERNAL EXPOSURE DURING PREGNANCY (Pregnant and received the vaccine) in a 36-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012L20A) for COVID-19 vaccination.     The patient's past medical history included Induced abortion on 17-Aug-2003, Miscarriage in November 2019, Pregnancy (Live, full-term birth) on 06-Oct-2014 and Pregnancy (Live, full-term birth) on 30-Oct-2017. Concurrent medical conditions included Hypothyroidism since 2018. Concomitant products included MINERALS NOS, VITAMINS NOS (PRENATAL VITAMINS [MINERALS NOS;VITAMINS NOS]) and LEVOTHYROXINE for an unknown indication.    On 16-Jan-2021 at 8:45 PM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. The patient's last menstrual period was on 25-Jun-2020 and the estimated date of delivery was 25-Mar-2021. On 16-Jan-2021, the patient experienced MATERNAL EXPOSURE DURING PREGNANCY (Pregnant and received the vaccine). The patient received mRNA-1273 (Moderna COVID-19 Vaccine) beginning around the  twenty-ninth week of the pregnancy.  On 16-Jan-2021, MATERNAL EXPOSURE DURING PREGNANCY (Pregnant and received the vaccine) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 10-Jul-2020, Pregnancy test: positive (Positive) Positive. On an unknown date, Ultrasound scan: normal (normal) ultrasound on 12 week and 20 week: report was normal.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   The patient had no maternal history of subfertility and had established prenatal care. There was no complications or acute illness reported during tis pregnancy. Conception date of patient was as 2020. On an unspecified date lab tests included NIPT testing on 12, 20 weeks, however the result was normal.  The female patient had four prior pregnancies. Second pregnancy, the delivery occurred on 06-Oct-2014, which was reported as full-term baby. Third pregnancy, the delivery occurred on 30-Oct-2017, which was reported as full-term baby.   Treatment information was not provided.
pt took oral typhoid starting 23oct96; 09nov96 pt had sx of rash in armpits, inner legs and a skin graft.  Rash was itchy; also had abdominal cramping & some diarrhea.  no fever. MD  in singapore said it was salmonella typhi & gave me
This spontaneous report as received from an unknown reporter refers to a patient of unknown age and gender. On 07-OCT-2014 the patient was vaccinated with M-M-R II which underwent a temperature excursion. No adverse event was reported. This is one of several reports from same reporter. Additional information has been requested.
Patient passed hit her head; Stroke; This is a spontaneous report from a non-contactable consumer (patient) via Pfizer sales representative. A 68-year-old female patient received single dose of BNT162B2(Solution for injection, lot number and exp date not reported), via an unspecified route of administration on an unspecified date at SINGLE DOSE for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient was not pregnant at the time of vaccination and was not pregnant at the time of reporting. The patient did not have COVID prior vaccination. On an unspecified date, the patient passed hit her head and had emergency surgery; and stroke. The adverse events resulted in: Hospitalization (date/s unspecified). The patient was not covid tested post vaccination. The outcome of events was unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Approximately 5 hours after administration, I developed severe pleuritic chest pain and tachycardia that self resolved after about an hour. This was followed by about 2 days of fatigue and myalgias that interfered with my daily activities that also self resolved. Had a large tender reaction on my left bicep for about 5 days after the injection.
Pt had had approx 1 wk of URIs x (rhinorrhea and cough) prior to onset of rxn, (URI sx began the night later vaccines given). Mother described "hive-like" rash on legs, regressed somewhat and Benadryl. Pt slept well. She awoke with more florid eruption on thighs, legs, back, arms. Swellin gof feet was painful and presented swelling. In office rash on back had faded, but mod to dark pink MP erythema iwth irregular border and sore lesions.
cough, slight wheeze, feeling in throat, she says she is coming down with bronchitis. started 12/8/21
Headaches; Weakness; Left side of rib cage hurts; Rash from neck to legs; This is a spontaneous report from a contactable other healthcare professional, the patient. A 46-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0161) via an unspecified route of administration in the left arm  on 18Apr2021 at 08:30 (at the age of 46-years-old) as a single dose for COVID-19 immunisation. The patient did not have any relevant medical history. The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any medication within two weeks of vaccination. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8730) via an unspecified route of administration in the left arm on 27Mar2021 at 15:30 (at the age of 46-years-old) as a single dose for COVID-19 immunisation. On 19Apr2021 at 07:00 the patient experienced headaches, weakness, left side of rib cage hurts and rash from neck to legs. The events resulted in doctor or other healthcare professional office/clinic visit. Since the vaccination, the patient had not been tested for COVID-19. Therapeutic measures were taken as a result of adverse events and included treatment with unspecified medication.  The clinical outcome of the events headaches, weakness, left side of rib cage hurts and rash from neck to legs was not recovered at the time of this report.   No follow-up attempts are needed. No further information is expected.
After receiving her first Moderna vaccine dose the patient became light-headed and laid down on the floor. Patient was monitored and felt better after approximately ten minutes. No treatment required.
No adverse reactions noted. Pt is doing fine this morning, no problems noted per mother this am.
This case was reported by a physician via sales rep and described the occurrence of injection site urticaria in a 4-year old female patient who received INFANRIX (batch number J7X72, expiry date 4th November 2016). Concomitant products included IPOL. On 15th July 2015, the patient received INFANRIX (intramuscular) .5 ml. On 15th July 2015, immediately after receiving INFANRIX, the patient experienced injection site urticaria. The patient was treated with epinephrine and DECADRON. On an unknown date, the outcome of the injection site urticaria was unknown. It was unknown if the reporter considered the injection site urticaria to be related to INFANRIX. Additional details were provided as follows: The INFANRIX was given on the left thigh, and IPOL was given on the right thigh. On 15th July 2015, immediately after receiving INFANRIX, the patient experienced injection site urticaria at the left thigh. The patient was treated with epinephrine and DECADRON at the physician's office. The patient's parents were told to monitor the situation to call back if there were any complications.
Rapid heartbeat, rash, hives, itching, felt flushed, no fever.  I still have mild symptoms.